<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta name="keywords" content="" />
<meta name="description" content="" />
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
<title>stockadvisor</title>
<link href="//fonts.googleapis.com/css?family=Abel|Arvo" rel="stylesheet" type="text/css" />
<link href="style.css" rel="stylesheet" type="text/css" media="screen" />
</head>
<body>
<div id="wrapper">
<div id="header">
<div id="logo">
<h1><a href="#">stock advisor</a></h1>
</div>
</div>
<div id="about">
<h2 class="title">Updated on: 04/13/2021, 17:06:22</h2>
<p><img src="images/pics01.jpg" alt="" width="225" height="225" class="alignleft" /><strong>Disclaimer:</strong> This is a project for fun and none of the stock recommendations here should be executed using real money. I am not a professional stock advisor. All trading decisions and associated risks are your own, and I do not take responsibility for any losses.<br /><br /><strong>About:</strong> Stocks are ranked using Deep Learning according to performance on different quantitative and qualitative metrics.Every day behind the scenes, our AI retrains itself and learns what prediction metrics correlate most strongly with next-day returns and then adjusts itself to make each successive day's predictions better. Stocks higher up on the list are predicted to have the highest returns over the next 3 weeks, but daily returns for individual stocks vary drastically. Forming a portfolio of multiple stocks can reduce daily risks.<br /><br /><strong>Contribute:</strong> Our mission is to further democratize finance by organizing high-quality publicly available information into actionable rankings. This information is free, however donations are highly appreciated at SegWit Bitcoin Wallet Address: bc1qxv7drjce5hx9l6eyht6ejtx2rex36an78fp82t</p>
<!-- AddToAny BEGIN -->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<a class="a2a_dd" href="https://www.addtoany.com/share"></a>
<a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_reddit"></a>
</div>
<script async src="https://static.addtoany.com/menu/page.js"></script>
<!-- AddToAny END --></div>
<div id="page">
<div id="content"><div class="post"><h2 class="title"><a href="#">GDRX</a></h2><p class="meta">Rank #1 | $39.0 / share</p><div class="entry">       <p>GoodRx Holdings, Inc. is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.</p>       <ul>
       <li>Robinhood Adjusted Rating: 68.085%</li>
       <li>Financial Modeling Prep Rating: 0.0%</li>
       <li>Finnhub Adjusted Rating: 76.582%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 24.48%</li>
       <li>Social Media Sentiment: 29.128%</li>
       <li>Insider Trading Transactions Rating: -64.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">PLNT</a></h2><p class="meta">Rank #2 | $86.5 / share</p><div class="entry">       <p>Planet Fitness, Inc., together with its subsidiaries, franchises and operates fitness centers under the Planet Fitness name. It operates through three segments: Franchise, Corporate-Owned Stores, and Equipment. The Franchise segment is involved in franchising business in the United States, Puerto Rico, Canada, the Dominican Republic, Panama, Mexico, and Australia. The Corporate-Owned Stores segment operates corporate-owned stores in the United States and Canada. The Equipment segment engages in the sale of fitness equipment to franchisee-owned stores in the United States. As of December 31, 2019, the company had 2,001 stores, including 1,903 franchised and 98 corporate-owned stores in the District of Columbia, Puerto Rico, Canada, the Dominican Republic, Panama, Mexico, and Australia. Planet Fitness, Inc. was founded in 1992 and is headquartered in Hampton, New Hampshire.</p>       <ul>
       <li>Robinhood Adjusted Rating: 61.017%</li>
       <li>Financial Modeling Prep Rating: 0.0%</li>
       <li>Finnhub Adjusted Rating: 76.923%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $91.8 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 40.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">NVCR</a></h2><p class="meta">Rank #3 | $197.33 / share</p><div class="entry">       <p>NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and NovoTTF-100L, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients with glioblastoma. It is also developing products that are in Phase 2 pilot and Phase 3 pivotal trials for brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, and mesothelioma. The company markets its products in the European Union, Japan, and internationally. It has a clinical trial collaboration agreement with MSD to evaluate tumor treating fields together with KEYTRUDA, an anti-PD-1 therapy; and a strategic alliance with the NYU Grossman School of Medicine's Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. NovoCure Limited was founded in 2000 and is based in Saint Helier, Jersey.</p>       <ul>
       <li>Robinhood Adjusted Rating: 37.5%</li>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Finnhub Adjusted Rating: 64.762%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 79.46%</li>
       <li>Fair Stock Price Estimate: $199.6 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -16.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">PINS</a></h2><p class="meta">Rank #4 | $83.9 / share</p><div class="entry">       <p>Pinterest, Inc. provides visual discovery engine in the United States and internationally. The company's engine allows people to find inspiration for their lives, including recipes, home and style ideas, travel destinations, and others. It shows them visual recommendations based on people personal taste and interests. The company was formerly known as Cold Brew Labs Inc. and changed its name to Pinterest, Inc. in April 2012. Pinterest, Inc. was founded in 2008 and is headquartered in San Francisco, California.</p>       <ul>
       <li>Suggested By Multiple Sources</li>
       <li>Robinhood Adjusted Rating: 60.952%</li>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 77.037%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 87.5%</li>
       <li>Social Media Sentiment: 50.048%</li>
       <li>Fair Stock Price Estimate: $84.67 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -56.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">KSU</a></h2><p class="meta">Rank #5 | $260.15 / share</p><div class="entry">       <p>Kansas City Southern, a transportation holding company, provides domestic and international rail transportation services in North America. The company serves a ten-state region in the midwest and southeast regions of the United States and has the shortest north/south rail route between Kansas City, Missouri, and ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas. It operates a commercial corridor of the Mexican railroad system and has its direct rail passageway between Mexico City and Laredo, Texas. The company provides rail access to the United States and Mexico border crossing at Nuevo Laredo, Tamaulipas; and controls and operates the southern half of the rail bridge at Laredo, Texas, as well as the northern half of this bridge. Kansas City Southern also provides rail access to the port of Lazaro Cardenas on the Pacific Ocean; and owns a 157-mile rail line extending from Laredo, Texas to the port city of Corpus Christi, Texas. Its rail network comprises approximately 6,700 route miles extending from the Midwest and Southeast portions of the United States south into Mexico. The company serves the chemical and petroleum, industrial and consumer products, agriculture and minerals, energy, intermodal, and automotive markets. Kansas City Southern was founded in 1887 and is headquartered in Kansas City, Missouri.</p>       <ul>
       <li>Robinhood Adjusted Rating: 54.237%</li>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Finnhub Adjusted Rating: 71.631%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 24.48%</li>
       <li>Social Media Sentiment: 24.489%</li>
       <li>Fair Stock Price Estimate: $261.64 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 4.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">FB</a></h2><p class="meta">Rank #6 | $309.76 / share</p><div class="entry">       <p>Facebook, Inc. develops products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and in-home devices worldwide. The company's products include Facebook that enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers; Instagram, a community for sharing photos, videos, and private messages; Messenger, a messaging application for people to connect with friends, family, groups, and businesses across platforms and devices; and WhatsApp, a messaging application that is used by people and businesses to communicate in a private way. It also provides Oculus, a hardware, software, and developer ecosystem, which allows people to come together and connect with each other through its Oculus virtual reality products. Facebook, Inc. was founded in 2004 and is headquartered in Menlo Park, California.</p>       <ul>
       <li>Robinhood Adjusted Rating: 87.31%</li>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 93.738%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 40.0%</li>
       <li>Social Media Sentiment: -57.162%</li>
       <li>Fair Stock Price Estimate: $315.49 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -80.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">MED</a></h2><p class="meta">Rank #7 | $234.01 / share</p><div class="entry">       <p>Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through direct ecommerce platform and franchise weight control center channels. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.</p>       <ul>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>Social Media Sentiment: 33.634%</li>
       <li>Fair Stock Price Estimate: $247.05 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -20.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">SWAV</a></h2><p class="meta">Rank #8 | $141.4 / share</p><div class="entry">       <p>ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.</p>       <ul>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 72.826%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $142.95 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -76.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">RDFN</a></h2><p class="meta">Rank #9 | $66.39 / share</p><div class="entry">       <p>Redfin Corporation operates as a real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; originates and sells mortgages; and buys and sells homes. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.</p>       <ul>
       <li>Robinhood Adjusted Rating: 27.119%</li>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Finnhub Adjusted Rating: 54.412%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Social Media Sentiment: 66.399%</li>
       <li>Fair Stock Price Estimate: $75.78 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -64.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">ECL</a></h2><p class="meta">Rank #10 | $217.94 / share</p><div class="entry">       <p>Ecolab Inc. provides water, hygiene, and energy technologies and services worldwide. The company operates through Global Industrial, Global Institutional, Global Energy, and Other segments. Its Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions primarily to industrial customers within the manufacturing, food and beverage processing, chemical, mining and primary metals, power generation, pulp and paper, and commercial laundry industries. The company's Global Institutional segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, healthcare, government, education, and retail industries. Its Global Energy segment offers the process chemicals and water treatment needs of the petroleum and petrochemical industries in upstream and downstream applications. This segment also provides additives for drilling and well stimulation, corrosion inhibitors, oil and water separation, scale control, paraffin and asphaltene control, biocides, hydrate control, hydrogen sulfide removal, oil dispersants, foamers and anti-foamers, flow improvers, anti-foulants, crude desalting, monomer inhibitors, anti-oxidants, fuel and lubricant additives, and water treatment. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also produces and sells colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries. Ecolab Inc. sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in St. Paul, Minnesota.</p>       <ul>
       <li>Robinhood Adjusted Rating: 37.838%</li>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Finnhub Adjusted Rating: 54.321%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Social Media Sentiment: 33.634%</li>
       <li>Fair Stock Price Estimate: $222.31 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 20.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">RILY</a></h2><p class="meta">Rank #11 | $69.3 / share</p><div class="entry">       <p>B. Riley Financial, Inc., through its subsidiaries, provides collaborative financial services and solutions in North America, Australia, and Europe. The Capital Markets segments offers range of investment banking, corporate finance, consulting, financial advisory, research, securities lending, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. This segment also provides merger and acquisitions, restructuring advisory, initial and secondary public offerings, and institutional private placements services; asset management services; manages various private and public funds for institutional and individual investors; and trades in equity securities. The Auction and Liquidation Segment offers retail store liquidation, and wholesale and industrial assets disposition services. The Valuation and Appraisal segment provides valuation and appraisal services, which include valuation of assets to financial institutions, lenders, private equity firms, and other capital provider. The Principal Investments - United Online and magicJack segment provides consumer subscription services consisting of Internet access services and devices under the NetZero and Juno brands, as well as voice over IP cloud-based technology and communication services. The Brands segments provides licensing of a brand investment portfolio, including Catherine Malandrino, English Laundry, Joan Vass, Kensie Girl, Limited Too, and Nanette Lepore. In addition, it offers advisory services to private funds, and institutional and high net worth investors; brokerage services; senior secured and second lien secured loans to middle market public and the private U.S. companies; and consulting services to shareholders, creditors, and companies. The company was formerly known as Great American Group, Inc. and changed its name to B. Riley Financial, Inc. in November 2014. B. Riley Financial, Inc. was founded in 1973 and is headquartered in Los Angeles, California.</p>       <ul>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $70.86 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 48.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">NYT</a></h2><p class="meta">Rank #12 | $48.09 / share</p><div class="entry">       <p>The New York Times Company, together with its subsidiaries, provides news and information for readers and viewers across various platforms worldwide. It offers The New York Times (The Times), a daily and Sunday newspaper in the United States, as well as international edition of The Times; and operates the NYTimes.com Website. The company also transmits articles, graphics, and photographs from The Times and other publications to approximately 1,500 newspapers, magazines, and Websites; licenses electronic databases to resellers in the business, professional, and library markets; and offers magazine licensing, news digests, book development, and rights and permissions. In addition, it engages in the NYT Live business, a platform for its live journalism; operates Wirecutter, a product review and recommendation Website that serves as a guide to technology gear, home products, and other consumer goods; develops mobile applications, including Crossword and Cooking products; prints products for third parties; and offers other products and services. The company was founded in 1851 and is headquartered in New York, New York.</p>       <ul>
       <li>Robinhood Adjusted Rating: 68.571%</li>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Finnhub Adjusted Rating: 77.32%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $49.79 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 16.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">IIPR</a></h2><p class="meta">Rank #13 | $190.64 / share</p><div class="entry">       <p>Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.</p>       <ul>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 86.239%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Social Media Sentiment: 42.186%</li>
       <li>Fair Stock Price Estimate: $202.49 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: 0.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">ZM</a></h2><p class="meta">Rank #14 | $342.75 / share</p><div class="entry">       <p>Zoom Video Communications, Inc. provides a video-first communications platform in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. The company's product portfolio includes Zoom Meetings that offers HD video, voice, chat, and content sharing through mobile devices, desktops, laptops, telephones, and conference room systems; Zoom Phone, an enterprise cloud phone system that provides secure call routing, call queuing, call detail reports, call recording, call quality monitoring, voicemail, switch to video, and other services, as well as inbound and outbound calling services; and Zoom Chat enables sharing messages, images, audio files, and content in desktop, laptop, tablet, and mobile devices for meeting and phone customers. It also offers Zoom Rooms, a software-based conference room system; Zoom Conference Room Connector, a gateway for SIP/H.323 endpoints to join Zoom meetings; and Zoom Video Webinars enables users to conduct large-scale online events, such as town hall meetings, workshops, and marketing presentations. In addition, the company provides Zoom for Developers that allows developers to integrate its video, phone, chat, and content sharing into other applications, as well as manages Zoom accounts; and Zoom App Marketplace enhance developers to publish their apps. It serves education, entertainment/media, enterprise infrastructure, finance, government, healthcare, manufacturing, non-profit/not for profit and social impact, retail/consumer products, and software/Internet industries, as well as individuals. Zoom Video Communications, Inc. has partnership with ServiceNow. The company was formerly known as Zoom Communications, Inc. and changed its name to Zoom Video Communications, Inc. in May 2012. Zoom Video Communications, Inc. was founded in 2011 and is headquartered in San Jose, California.</p>       <ul>
       <li>Robinhood Adjusted Rating: 48.0%</li>
       <li>Financial Modeling Prep Rating: 50.0%</li>
       <li>Finnhub Adjusted Rating: 69.072%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 64.73%</li>
       <li>Social Media Sentiment: 76.155%</li>
       <li>Recent Death Cross</li>
       <li>Fair Stock Price Estimate: $351.95 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -92.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">TXG</a></h2><p class="meta">Rank #15 | $197.36 / share</p><div class="entry">       <p>10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. Its company offers chromium instruments, enzymes, microfluidic chips, slides, reagents, and other consumable products. The company's single cell solution runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics, including the physical organization of DNA; single cell CNV for measuring cellular heterogeneity through DNA changes, such as copy number variation; and visium spatial gene expression solution that measures the spatial gene expression patterns across a tissue sample. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. 10x Genomics, Inc. was founded in 2012 and is headquartered in Pleasanton, California.</p>       <ul>
       <li>Robinhood Adjusted Rating: 91.429%</li>
       <li>Financial Modeling Prep Rating: 0.0%</li>
       <li>Finnhub Adjusted Rating: 91.87%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Social Media Sentiment: 69.102%</li>
       <li>Fair Stock Price Estimate: $203.35 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -80.0%</li>
       </ul>
</div></div><div class="post"><h2 class="title"><a href="#">CARA</a></h2><p class="meta">Rank #16 | $27.49 / share</p><div class="entry">       <p>Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. Its lead product candidate includes KORSUVA (CR845/ difelikefalin) injection, which is in Phase III clinical trial for the treatment of patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP) undergoing hemodialysis. The company is also developing Oral KORSUVA (CR845/difelikefalin), which has completed Phase II clinical trial for the treatment of pruritus in stage III-V CKD patients; in Phase II clinical trial for treating pruritus chronic liver disease; and in Phase II clinical trial for the treatment of pruritus associated with atopic dermatitis. In addition, it is developing CR845/difelikefalin Injection, which has completed Phase II/III clinical trial for the treatment of acute post-operative pain. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing CR845/difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing CR845/difelikefalin in South Korea. Cara Therapeutics, Inc. was founded in 2004 and is headquartered in Stamford, Connecticut.</p>       <ul>
       <li>Financial Modeling Prep Rating: 100.0%</li>
       <li>Finnhub Adjusted Rating: 91.935%</li>
       <li>Technical Analysis Aggregate Rating: neutral</li>
       <li>News Sentiment: 50.0%</li>
       <li>Fair Stock Price Estimate: $28.11 (Stock is Undervalued)</li>
       <li>Insider Trading Transactions Rating: -12.0%</li>
       </ul>
</div></div></div>
</div>
</div>
<div id="footer">
<p>&copy; Jonathan Davies. All rights reserved. Design by <a href="http://templated.co" rel="nofollow">TEMPLATED</a>.</p>
</div>
</body>
</html>